Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population

Abstract

Objective:To examine prescription Food and Drug Administration (FDA) C, D and X drugs in general obstetric population.Study Design:Historical cohort study.Result:A total of 18 575 women who gave a birth in Saskatchewan between January 1997 and December 2000 were included. Among them, 3604 (19.4%) received FDA C, D or X drugs at least once during pregnancy… (More)
DOI: 10.1038/jp.2008.6

3 Figures and Tables

Topics

  • Presentations referencing similar topics